CoChat

End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19

Open access

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.

Abstract

Despite a wealth of research regarding COVID-19, little evidence exists about cancer patients’ specific needs and experiences at end-of-life. This study retrospectively describes the care of 34 hospitalised cancer patients dying with COVID-19. The palliative care needs of patients were described. The main domains of end-of-life care service provision were evaluated including treatment of pain and other symptoms, communication and decision making at end-of-life and level of involvement of the palliative care team. Physical symptoms were managed with relatively low doses of end-of-life medications. High levels of patient and family anxiety, however, highlight the complexity of death from a stigmatised disease. Prompt acknowledgement of the vulnerability of advanced cancer patients with COVID-19 can facilitate proactive symptom management, anticipatory communication and enhance family support.

Overview

CoChat Summary

TL;DR

This retrospective single-center study describes end-of-life care for 34 hospitalized cancer patients who died with COVID-19 during the first two waves of the pandemic. It found that symptom management was generally low-dose and manageable, but patient and family anxiety, rapid deterioration, and communication challenges made the dying experience complex.

Key findings

  • 34 patients were included: 29 non-ventilated PCR-positive deaths and 5 additional cases with strong clinical suspicion of COVID-19.
  • Half of all patients had WHO performance status 3 at baseline, indicating substantial care needs.
  • End-of-life medication use was relatively modest: median total opioid dose in the last 24 h was 30 mg oral morphine equivalent (range 5–180 mg) and median benzodiazepine dose was 10 mg (range 0–30 mg); 79% (n = 27) required a continuous subcutaneous infusion in the last 24 h of life.
  • Palliative care was involved in most cases, but more often in wave 1 than wave 2 (89% [17/19] vs 73% [11/15]); all patients had DNACPR orders and treatment escalation plans in place at death.
  • Patient and family anxiety were the most prevalent issues; 50% of identified family concerns (n = 20) related to the unexpected rapid deterioration from COVID-19.

Methods

  • Retrospective service evaluation at a tertiary referral cancer centre; approved by the local Committee for Clinical Research (SE948).
  • Included all non-ventilated inpatients aged >18 years who died with confirmed PCR COVID-19 or strong clinical suspicion of COVID-19 during 25 March 2020–1 May 2020 and 5 December 2020–1 March 2021.
  • Data were extracted from medication charts and electronic records using a standardized proforma and analyzed with descriptive statistics in SPSS v27; IPOS scoring, documentation review, and thematic analysis of communication notes were used to assess symptoms, care planning, and family communication.

Limitations

  • The paper explicitly states the study is limited by the small numbers and its retrospective nature.
  • The authors note they did not have direct information on how patients and families perceived the end-of-life experience.
  • Ventilated and sedated patients were excluded, so findings do not apply to that subgroup.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/23743735221074171

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Patients’ World Health Organisation (WHO) performance status on admission.
Figure 1. Patients’ World Health Organisation (WHO) performance status on admission.CC BY-NC · PubMed Central
Figure 2. Identification of patient's individual needs using integrated palliative outcome scale (IPOS) on initial (IPOS 1) and subsequent assessment (IPOS 2), n = 34. Number (%) of patients scoring 2, 3 or 4 on IPOS items is presented to represent the number (%) of patients with moderate/severe/overwhelming symptoms or concerns in each IPOS domain. Physical symptoms: 2 = moderately, 3 = severely, 4 = overwhelmingly. Emotional symptoms (anxiety, family anxiety and depression): 2 = sometimes, 3 = most of the time, 4 = always. Feeling at peace, being able to share feelings, having enough information: 2 = sometimes, 3 = occasionally, 4 = not at all. Practical matters: 2 = problems partly addressed, 3 = problems hardly addressed, 4 = problems not addressed.
Figure 2. Identification of patient's individual needs using integrated palliative outcome scale (IPOS) on initial (IPOS 1) and subsequent assessment (IPOS 2), n = 34. Number (%) of patients scoring 2, 3 or 4 on IPOS items is presented to represent the number (%) of patients with moderate/severe/overwhelming symptoms or concerns in each IPOS domain. Physical symptoms: 2 = moderately, 3 = severely, 4 = overwhelmingly. Emotional symptoms (anxiety, family anxiety and depression): 2 = sometimes, 3 = most of the time, 4 = always. Feeling at peace, being able to share feelings, having enough information: 2 = sometimes, 3 = occasionally, 4 = not at all. Practical matters: 2 = problems partly addressed, 3 = problems hardly addressed, 4 = problems not addressed.CC BY-NC · PubMed Central

Verification

Claims the paper makes

1 Valid · 6 Not valid · 6 Not checked · 28 Own results and interpretations

21 more claims

Create a free account to see all 41 claims and to verify the 8 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Research works printed but not linked: 4

  1. UK CR, 2021, Cancer News [Internet]
  2. Selman L, 2021, medRxiv, 34, 1249
  3. Partnership NPEoLC, 2021, Ambitions for palliative and end of life care: A national framework for local action 2021–2026
  4. Bradshaw A, 2020, medRxiv, 35, 1225

Cited by

See all 4

Metadata

Authors
McFarlane, P., Halley, A., Kano, Y., Wade, N., Wilson, S., & Droney, J.
Affiliations
Royal Marsden NHS Foundation Trust (GB)
Corresponding author
McFarlane, Philippa
Venue
Journal of Patient Experience
Published
2022-01
Volume
9
Pages
23743735221074171-23743735221074171
ISSN
  • 2374-3735 (ISSN-L)
  • 2374-3743
OpenAlex
W4210567126
Cited by
4
References
23
Citations by year
2023: 1 · 2022: 3
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Patient Experience (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
COVID-19 pandemic, cancer patients, end-of-life care, palliative care, symptom management, pain management, end-of-life decisions, family anxiety, stigma, hospitalized patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19. https://app.cochat.ai/papers/10.1177/23743735221074171
The paper
McFarlane, P., Halley, A., Kano, Y., Wade, N., Wilson, S., & Droney, J. (2022). End-of-Life Experiences for Cancer Patients Dying in Hospital with COVID-19. Journal of Patient Experience. https://doi.org/10.1177/23743735221074171

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.